Tim Smith

This marketing authorization by the FDA allows the Hearing Aid Feature to be implemented alongside compatible Apple AirPod Pro headphones.

This analysis may help to inform research evaluating the value of obstructive sleep apnea treatments designed to minimize cardiovascular risk as well as related deaths among older patients.

In this survey, investigators sought to develop a definition for eczema flare which was patient-centered and based upon consensus.

These data may provide invaluable insights, given the lack of reliable methods for identifying newborns with increased risk of developing eczema.

These findings also highlight that an early response to alopecia areata treatment can be identified with trichoscopy.

These findings resulted from a systematic literature review highlighting the impact of stigma and lack of support on self-image for patients with eczema, psoriasis, HS, and other conditions.

This feature highlights the views of 3 experts on the integration of patient-reported outcomes into the management of psoriatic disease.

These data on depemokimab, a long-acting asthma treatment, suggest the medication reduces serious attacks by more than half and strongly reduces asthma exacerbations.

These data may help to inform and guide clinicians as well as policymakers in their allocation of efficient chronic urticaria management resources.

These real-world findings highlight the benefits of sustained dupilumab therapy for individuals with chronic rhinosinusitis with nasal polyps.

In this analysis, the differences in adverse events resulting from JAKi among adults and children were evaluated.

These findings further endorse the need for health care quality improvements for veterans, given the rates of melanoma, skin cancer, and psoriasis.

These data were presented at the European Society of Contact Dermatitis congress, with findings drawn from the CHECK and RWEAL studies on chronic hand eczema.

This Month in Review summarizes some of the most significant stories covered in the month of August in the pulmonary health space, including new research and FDA news.

In this review of August 2024, the editorial team highlighted major stories from the previous month related to FDA approvals and medications for atopic dermatitis and psoriasis.

These Mendelian analysis results highlight an association between alopecia areata and asthma, indicating a mediating role of IL-33.

These data suggest that there are a subset of individuals with complete skin clearance of their psoriasis who report residual effects of their condition.

These data suggest the necessity of caution when clinicians treat select patient groups with dupilumab for atopic dermatitis.

This systematic review and meta-analysis looks at trends around the world regarding patients with vitiligo, highlighting prevalence and incidence.

These data are encouraging for tralokinumab, though additional observational research with more individuals with atopic dermatitis or longer follow-up periods may be necessary.

These data reaffirm NB-UVB phototherapy’s use in treating patients with atopic dermatitis and psoriasis, suggesting improvement in patient-reported outcome measures.

This analysis was designed to examine ChatGPT’s accuracy in diagnosing dermatologic conditions among those with and without skin of color.

During this segment of a recent Lungcast, Mora and Sadeameli speak about 2 key topics: vaping and e-cigarette use among children as well as vaccinations and related misinformation.

This analysis was conducted to evaluate the efficacy and safety results of AIT for patients with house dust mite allergies.

In this systematic review and meta-analysis, the investigators highlighted topical roflumilast’s success in clinical milestones such as IGA and PASI score success.

This analysis evaluated the long-term follow-up and risks linked to the self-reported penicillin allergy persistence after a successful oral penicillin challenge and allergy label removal.

These data suggest that the choice of allergens for patch testing should remain the same among individuals with and without atopic dermatitis.

These data on systemic inflammatory biomarkers for patients with eczema may allow for more targeted treatments and for greater personalization of medicine for this skin condition.

The Harris Poll evaluated patient preferences for psoriasis therapy, highlighting patient views through an online survey.

These data highlight the necessity of equality in access to treatment and to the future development of psychological intervention measures using country-specific differences.